2024
DOWNLOAD THE PROGRAM
RATIONALE
Minimally Invasive Thyroid Treatments (MITT) are increasingly applied in the clinical practice all over Europe for the treatment for benign and malignant thyroid diseases.
The MITT group has been founded in 2018 in Italy to promote multidisciplinary partnership among physicians with different expertise who share the interest in MITT and to improve the clinical, diagnostic, and therapeutic management of benign and malignant thyroid and parathyroid glands diseases.
During the 2024 MITT meeting, the present guidelines on both benign and malignant thyroid disease management will be presented, and the most widely used techniques for ablation will be presented by renowned experts in the field. Also, the most updated evidence on the application of MITT in benign thyroid nodules, autonomously functioning thyroid nodules, and malignant tumours will be illustrated.
Furthermore, a series of real-life clinical cases will be presented and discussed between the expert panel and the participants.
During the second day, the organization of a thyroid ablation clinical practice will be discussed, with particular focus on preoperative and postoperative patients’ management, possible type of anaesthesia, with the discussion of a video-recorded treatment.
In the end, a series of “hot topics” on minimally invasive treatments of the thyroid will be presented and discussed with the participants, including treatment of parathyroid adenomas, complications of MITT and their management, and the problem of nodule regrowth.
Hands-on workshops will also be available at the end of the meeting for those who will want to try the different available technologies and techniques on dedicated phantoms.
The MITT group has been founded in 2018 in Italy to promote multidisciplinary partnership among physicians with different expertise who share the interest in MITT and to improve the clinical, diagnostic, and therapeutic management of benign and malignant thyroid and parathyroid glands diseases.
During the 2024 MITT meeting, the present guidelines on both benign and malignant thyroid disease management will be presented, and the most widely used techniques for ablation will be presented by renowned experts in the field. Also, the most updated evidence on the application of MITT in benign thyroid nodules, autonomously functioning thyroid nodules, and malignant tumours will be illustrated.
Furthermore, a series of real-life clinical cases will be presented and discussed between the expert panel and the participants.
During the second day, the organization of a thyroid ablation clinical practice will be discussed, with particular focus on preoperative and postoperative patients’ management, possible type of anaesthesia, with the discussion of a video-recorded treatment.
In the end, a series of “hot topics” on minimally invasive treatments of the thyroid will be presented and discussed with the participants, including treatment of parathyroid adenomas, complications of MITT and their management, and the problem of nodule regrowth.
Hands-on workshops will also be available at the end of the meeting for those who will want to try the different available technologies and techniques on dedicated phantoms.
PROGRAM
Thursday, 15th February, 2024
13.15-13.40 Registration
13.40-14.00 Welcome and introduction
Giovanni Mauri, Milan – IT, Luca M. Sconfienza, Milan – IT, Luigi Solbiati, Milan - IT
Roberto Crugnola - CEO IRCCS Ospedale Galeazzi-Sant’Ambrogio, Milan - IT
Renato Cozzi - President AME, Milan - IT
European guidelines on MITT
Chairpersons: Hervè Monpeyssen, Paris - FR, Luca M. Sconfienza, Milan - IT
14.00-14.10 Guidelines on benign thyroid nodules - Enrico Papini, Albano Laziale, RM - IT
14.10-14.20 Guidelines on malignant thyroid tumors - Giovanni Mauri, Milan - IT
14.20-14.30 Discussion
Technologies and techniques for MITT
Chairpersons: Gioacchino Giugliano, Milan - IT, Luigi Solbiati, Milan - IT
14.30-14.40 RFA - Pál Ákos Deák, Budapest - HU
14.40-14.50 Laser - Daniela Sansone, Turin - IT
14.50-15.00 MWA - Stefano Spiezia, Naples - IT
15.00-15.10 Not only mooving shot - Camillo Aliberti, Verona - IT; Andrea Casaril , Verona - IT
15.10-15.20 How I make the choice - Edouard Ghanassia, Sete - FR
15.20-15.35 Discussion
Present evidences on results of MITT
Chairpersons: Luca Persani, Milan - IT, Edouard Ghanassia, Sete - FR
15.35-15.45 Benign thyroid nodules - Fulvio Stacul, Trieste - IT
15.45-15.55 AFTN - Johannes-Paul Richter, Berlin - DE
15.55-16.05 Malignant thyroid tumors - Teresa Dionisio, Vila Nova de Gaia - PT
16.05-16.20 Discussion
16.20-16.50 BREAK
Case based discussion
Chairpersons: Laura Fugazzola, Milan - IT, Myrsini Gkeli, Athens - GR
16.50-17.10 Case 1 (benign thyroid nodule) - Eveline Slotema, Marseille - FR
17.10-17.30 Case 2 (AFTN) - Marco Dell’Acqua, Milan - IT
17.30-17.50 Case 3 (multinodular goiter) - Gulsah Yildirim, Istanbul - TR
17.50-18.10 Case 4 (PTMC) - Giovanni Antonelli, Naples - IT
18.10-18.30 Case 5 (nodule rupture) - Hervè Monpeyssen, Paris - FR
18.30-18.50 Case 6 (parathyroid adenoma) - Claudio Cusini, Milan - IT
Friday, 16th February, 2024
Organizing a MITT practice
Chairpersons: Maurilio Deandrea, Turin - IT, Hossam A. Ghazi, Mansoura - EG
08.30-08.40 Preprocedural workup and postoperative management - Lorenzo Monfardini, Milan - IT
08.40-08.50 Discussion
08.50-09.00 How we do it (with video case) - Daniele Maiettini, Milan - IT
09.00-09.10 Discussion
09.10-09.20 Which anaesthesia? - Monika Sallai, Budapest - HU
09.20-09.30 Discussion
Hot topics I
Chairpersons: Andrea Frasoldati, Reggio Emilia - IT, Maria Cecilia Mariani, Milan - IT
09.30-09.40 Tiny lesions (<5 mL) and big lesions (>30 mL) - Gilles Russ, Paris - FR
09.40-09.50 Discussion
09.50-10.00 US and clinical features to predict
treatment response - Izabella Costa Santos, Rio de Janeiro - BR
10.00-10.10 Discussion
10.10-10.20 Complications of MITT - Robert Eisele, Oranienburg - DE
10.20-10.30 Discussion
10.30-10.40 Parathyroid ablation - Luigi Solbiati, Milan - IT
10.40-10.50 Discussion
10.50-11.20 BREAK
Hot topics II
Chairpersons: Teresa Dionisio, Vila Nova de Gaia - PT, Carmela Asteria, Milan - IT
11.20-11.30 Nodule regrowth - Stella Bernardi, Trieste - IT
11.30-11.40 Discussion
11.40-11.50 The patient perspective - Jennifer Holkem, Huntsville - USA
11.50-12.00 Discussion
12.00-12.10 Economical impact of introduction of MITT - Giampaolo Papi, Carpi (MO) - IT
12.10-12.20 Discussion
12.20-13.05 Conclusions and future perspectives
Edouard Ghanassia, Sete - FR, Giovanni Mauri, Milan - IT
Hands on course (2 parallel sessions)
Not accredited CME - Reserved for n. 60 Participants
14.00-17.30
Participants will have the opportunity to perform ablation on dedicated phantoms
with different RFA and MWA ablation systems on 5 different stations.